BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22283898)

  • 1. 'Sputnik': a programmatic approach to improve tuberculosis treatment adherence and outcome among defaulters.
    Gelmanova IY; Taran DV; Mishustin SP; Golubkov AA; Solovyova AV; Keshavjee S
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1373-9. PubMed ID: 22283898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmatic management of multidrug-resistant tuberculosis: models from three countries.
    Furin J; Bayona J; Becerra M; Farmer P; Golubkov A; Hurtado R; Joseph JK; Keshavjee S; Ponomarenko O; Rich M; Shin S
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1294-300. PubMed ID: 21669029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia.
    Shin SS; Pasechnikov AD; Gelmanova IY; Peremitin GG; Strelis AK; Mishustin S; Barnashov A; Karpeichik Y; Andreev YG; Golubchikova VT; Tonkel TP; Yanova GV; Nikiforov M; Yedilbayev A; Mukherjee JS; Furin JJ; Barry DJ; Farmer PE; Rich ML; Keshavjee S
    Int J Tuberc Lung Dis; 2006 Apr; 10(4):402-8. PubMed ID: 16602404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors and mortality associated with treatment default in pulmonary tuberculosis.
    Kliiman K; Altraja A
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):454-63. PubMed ID: 20202304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of collaborative tuberculosis and human immunodeficiency virus activities in Phnom Penh, Cambodia.
    Tsurugi Y; Eam KK; Eang MT; Uehara R; Nakamura Y; Murakami K; Sugiyama T; Yamada N; Ishikawa N
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1535-9, i. PubMed ID: 22008769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community-based management of multidrug-resistant tuberculosis in South Africa.
    Bekker LG; Wood R
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):379. PubMed ID: 20202291
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of Ecuador's national monetary incentive program on adherence to treatment for drug-resistant tuberculosis.
    Sripad A; Castedo J; Danford N; Zaha R; Freile C
    Int J Tuberc Lung Dis; 2014 Jan; 18(1):44-8. PubMed ID: 24365551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
    Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
    Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and disease.
    Keshavjee S; Gelmanova IY; Pasechnikov AD; Mishustin SP; Andreev YG; Yedilbayev A; Furin JJ; Mukherjee JS; Rich ML; Nardell EA; Farmer PE; Kim JY; Shin SS
    Ann N Y Acad Sci; 2008; 1136():1-11. PubMed ID: 17954675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-based treatment for multidrug-resistant tuberculosis in rural KwaZulu-Natal, South Africa.
    Heller T; Lessells RJ; Wallrauch CG; Bärnighausen T; Cooke GS; Mhlongo L; Master I; Newell ML
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):420-6. PubMed ID: 20202299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment interruptions and duration associated with default among new patients with tuberculosis in six regions of Russia.
    Jakubowiak W; Bogorodskaya E; Borisov S; Danilova I; Kourbatova E
    Int J Infect Dis; 2009 May; 13(3):362-8. PubMed ID: 19008141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing a public-private mix model for tuberculosis treatment in urban Pakistan: lessons and experiences.
    Naqvi SA; Naseer M; Kazi A; Pethani A; Naeem I; Zainab S; Fatmi Z
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):817-21. PubMed ID: 22507031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strengthening tuberculosis patient referral mechanisms among health facilities in Punjab, Pakistan.
    Badar D; Ohkado A; Naeem M; Khurshid-ul-Zaman S; Tsukamoto M
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1362-6. PubMed ID: 22283896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care.
    Brust JC; Shah NS; Scott M; Chaiyachati K; Lygizos M; van der Merwe TL; Bamber S; Radebe Z; Loveday M; Moll AP; Margot B; Lalloo UG; Friedland GH; Gandhi NR
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):998-1004. PubMed ID: 22668560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consulting private health care providers aggravates treatment delay in urban South African tuberculosis patients.
    Van Wyk SS; Enarson DA; Beyers N; Lombard C; Hesseling AC
    Int J Tuberc Lung Dis; 2011 Aug; 15(8):1069-76. PubMed ID: 21740670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The experience of implementing a 'TB village' for a pastoralist population in Cherrati, Ethiopia.
    Tayler-Smith K; Khogali M; Keiluhu K; Jemmy JP; Ayada L; Weyeyso T; Issa AM; De Maio G; Harries AD; Zachariah R
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1367-72. PubMed ID: 22283897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and follow-up of HIV-negative multidrug-resistant tuberculosis patients in an infectious diseases reference hospital, Buenos Aires, Argentina.
    Palmero DJ; Ambroggi M; Brea A; De Lucas M; Fulgenzi A; MartĂ­nez D; Mosca C; Musella R; Natiello M; Gonzalez C; Abbate E
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):778-84. PubMed ID: 15182150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Directly observed treatment is associated with reduced default among foreign tuberculosis patients in Thailand.
    Kapella BK; Anuwatnonthakate A; Komsakorn S; Moolphate S; Charusuntonsri P; Limsomboon P; Wattanaamornkiat W; Nateniyom S; Varma JK
    Int J Tuberc Lung Dis; 2009 Feb; 13(2):232-7. PubMed ID: 19146753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence after successful treatment among patients with multidrug-resistant tuberculosis.
    Lee J; Lim HJ; Cho YJ; Park YS; Lee SM; Yang SC; Yoo CG; Kim YW; Han SK; Yim JJ
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1331-3. PubMed ID: 22283890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.